BRPI0511421A - composições cosmética e farmacêutica para tratar materiais contendo queratina, uso de composições cosméticas, molécula efetora que liga queratina, uso da mesma, e, processo - Google Patents

composições cosmética e farmacêutica para tratar materiais contendo queratina, uso de composições cosméticas, molécula efetora que liga queratina, uso da mesma, e, processo

Info

Publication number
BRPI0511421A
BRPI0511421A BRPI0511421-7A BRPI0511421A BRPI0511421A BR PI0511421 A BRPI0511421 A BR PI0511421A BR PI0511421 A BRPI0511421 A BR PI0511421A BR PI0511421 A BRPI0511421 A BR PI0511421A
Authority
BR
Brazil
Prior art keywords
keratin
cosmetic
compositions
containing materials
effector molecule
Prior art date
Application number
BRPI0511421-7A
Other languages
English (en)
Inventor
Heiko Barg
Thomas Subkowski
Hans-Georg Lemaire
Claus Bollschweiler
Arne Ptock
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE200410025805 external-priority patent/DE102004025805A1/de
Priority claimed from DE200510011988 external-priority patent/DE102005011988A1/de
Application filed by Basf Ag filed Critical Basf Ag
Publication of BRPI0511421A publication Critical patent/BRPI0511421A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/002—Aftershave preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners

Abstract

COMPOSIçõES COSMéTICAS E FARMACêUTICAS PARA TRATAR MATERIAIS CONTENDO QUERATINA, USO DE COMPOSIçõES COSMéTICAS, MOLéCULA EFETORA QUE LIGA QUERATINA, USO DA MESMA, E, PROCESSO A invenção diz respeito a novas substâncias ativas de proteína que liga queratina, e também à sua produção e uso.
BRPI0511421-7A 2004-05-24 2005-05-24 composições cosmética e farmacêutica para tratar materiais contendo queratina, uso de composições cosméticas, molécula efetora que liga queratina, uso da mesma, e, processo BRPI0511421A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE200410025805 DE102004025805A1 (de) 2004-05-24 2004-05-24 Keratin-bindende Effektormoleküle
DE200510011988 DE102005011988A1 (de) 2005-03-14 2005-03-14 Die vorliegende Erfindung betrifft die Verwendung von Keratin-bindenden Polypeptiden und ihre Herstellung
PCT/EP2005/005599 WO2005115306A2 (de) 2004-05-24 2005-05-24 Keratin-bindende polypeptide

Publications (1)

Publication Number Publication Date
BRPI0511421A true BRPI0511421A (pt) 2008-01-29

Family

ID=35134164

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0511421-7A BRPI0511421A (pt) 2004-05-24 2005-05-24 composições cosmética e farmacêutica para tratar materiais contendo queratina, uso de composições cosméticas, molécula efetora que liga queratina, uso da mesma, e, processo

Country Status (13)

Country Link
US (1) US20080075684A1 (pt)
EP (1) EP1763334B1 (pt)
JP (1) JP2008500301A (pt)
AT (1) ATE417595T1 (pt)
AU (1) AU2005247092B2 (pt)
BR (1) BRPI0511421A (pt)
CA (1) CA2563999A1 (pt)
DE (1) DE502005006284D1 (pt)
ES (1) ES2317237T3 (pt)
MX (1) MXPA06013458A (pt)
NZ (1) NZ551366A (pt)
RU (1) RU2411029C2 (pt)
WO (1) WO2005115306A2 (pt)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7807141B2 (en) 2003-09-08 2010-10-05 E.I. Du Pont De Nemours And Company Peptide-based oral care surface reagents for personal care
US7585495B2 (en) 2003-09-08 2009-09-08 E. I. Du Pont De Nemours And Company Method for identifying shampoo-resistant hair-binding peptides and hair benefit agents therefrom
US7285264B2 (en) * 2003-09-08 2007-10-23 E.I. Du Pont De Nemours And Company Peptide-based body surface coloring reagents
US7220405B2 (en) 2003-09-08 2007-05-22 E. I. Du Pont De Nemours And Company Peptide-based conditioners and colorants for hair, skin, and nails
EP2371363B1 (en) * 2004-01-22 2020-04-08 University of Miami Coenzyme Q10 formulations for use in the treatment of solid tumours
JP5250264B2 (ja) 2005-02-07 2013-07-31 ビーエーエスエフ ソシエタス・ヨーロピア 新規ハイドロフォビン融合タンパク質、その製造および使用
US8859106B2 (en) 2005-03-31 2014-10-14 Basf Se Use of polypeptides in the form of adhesive agents
DE502006005460D1 (de) 2005-04-01 2010-01-07 Basf Se Bohrspülung enthaltend hydrophobin
EA014384B1 (ru) 2005-04-01 2010-10-29 Басф Акциенгезелльшафт Промывочный буровой раствор, содержащий гидрофобин
DE102005027139A1 (de) 2005-06-10 2006-12-28 Basf Ag Neue Cystein-verarmte Hydrophobinfusionsproteine, deren Herstellung und Verwendung
DE102005029704A1 (de) * 2005-06-24 2007-01-11 Basf Ag Verwendung von Hydrophobin-Polypeptiden sowie Konjugaten aus Hydrophobin-Polypeptiden mit Wirk-oder Effektstoffen und ihre Herstellung sowie deren Einsatz in der Kosmetik
DE102005048720A1 (de) 2005-10-12 2007-04-19 Basf Ag Verwendung von Proteinen als Antischaum-Komponente in Kraftstoffen
CA2630696A1 (en) * 2005-11-24 2007-05-31 Basf Se Keratin-binding effector molecules and method for the production thereof by coupling keratin-binding polypeptides with effector molecules that support carboxylic groups or sulfonic acid groups
US20090099075A1 (en) * 2005-11-24 2009-04-16 Basf Se Chimeric Keratin-Binding Effector Proteins
CA2630903A1 (en) * 2005-11-24 2007-12-27 Basf Se Keratin-binding effector molecules, and method for the production thereof
AU2006319259A1 (en) * 2005-12-01 2007-06-07 Basf Se Keratin-binding effector molecules containing reactive dyes
WO2008019965A1 (de) 2006-08-15 2008-02-21 Basf Se Verfahren zur herstellung von trockenen freifliessenden hydrophobinzubereitungen
US20080280810A1 (en) * 2006-10-30 2008-11-13 O'brien John P Peptides having affinity for body surfaces
US20080175798A1 (en) * 2006-12-11 2008-07-24 Beck William A Peptide-based hair protectants
WO2008116135A2 (en) 2007-03-22 2008-09-25 Cytotech Labs, Llc Topical formulations having enhanced bioavailability
DE102007058845A1 (de) * 2007-12-05 2009-06-10 Henkel Ag & Co. Kgaa Haarreinigungsmittel mit Tensid-/Verdickerkombination
EP3015104A1 (en) 2008-04-11 2016-05-04 Berg LLC Methods and use of inducing apoptosis in cancer cells
FR2932087B1 (fr) * 2008-06-10 2012-10-12 Oreal Utilisation cosmetique de proteines de type desmoplakine pour le traitement de la secheresse cutanee
US8287845B2 (en) * 2008-12-18 2012-10-16 E I Du Pont De Nemours And Company Hair-binding peptides
US20100158822A1 (en) * 2008-12-18 2010-06-24 E .I. Du Pont De Nemours And Company Peptides that bind to silica-coated particles
US20100158846A1 (en) * 2008-12-18 2010-06-24 E. I. Du Pont De Nemours And Company Hair-binding peptides
US8697654B2 (en) * 2008-12-18 2014-04-15 E I Du Pont De Nemours And Company Peptide linkers for effective multivalent peptide binding
CN102481271A (zh) 2009-05-11 2012-05-30 博格生物系统有限责任公司 利用表观代谢转变剂、多维细胞内分子或环境影响剂治疗代谢障碍的方法
NZ701451A (en) 2010-03-12 2016-09-30 Berg Llc Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof
US20120269867A1 (en) 2011-04-04 2012-10-25 Jimenez Joaquin J Methods of treating central nervous system tumors
CN107095863A (zh) 2011-06-17 2017-08-29 博格有限责任公司 可吸入药物组合物
US9745543B2 (en) 2012-09-10 2017-08-29 Ecolab Usa Inc. Stable liquid manual dishwashing compositions containing enzymes
US9622951B2 (en) 2012-10-29 2017-04-18 The Procter & Gamble Company Personal care compositions
CN113797343A (zh) 2013-04-08 2021-12-17 博格有限责任公司 使用辅酶q10联合疗法治疗癌症
DE102013213170A1 (de) 2013-07-04 2015-01-08 Beiersdorf Ag Octocrylenfreies, geruchsstabiles Sonnenschutzmittel
US9672952B2 (en) 2013-08-14 2017-06-06 Industrial Technology Research Institute Polymer and conductive composition
NZ717504A (en) 2013-09-04 2022-07-01 Berg Llc Methods of treatment of cancer by continuous infusion of coenzyme q10
BR112020019944A2 (pt) * 2018-04-13 2021-01-26 Massachusetts Institute Of Technology tratamentos modificados para reparo do cabelo e retenção de cor duradoura
BR112022023878A2 (pt) 2020-06-02 2022-12-20 Unilever Ip Holdings B V Composição de limpeza pessoal, método para fornecer fator de proteção solar melhorado e uso da composição

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2748174B2 (ja) * 1990-01-29 1998-05-06 株式会社成和化成 化粧品基剤
GB9217444D0 (en) * 1992-08-17 1992-09-30 Unilever Plc Compounds compositions and methods for producing pigmentation in hair or skin
ES2101263T3 (es) * 1993-02-19 1997-07-01 Howard Green Composiciones que contienen proteinas de corneocitos.
JP3446980B2 (ja) * 1994-12-08 2003-09-16 株式会社成和化成 毛髪化粧料
DE19626762A1 (de) * 1996-07-03 1998-01-08 Basf Ag Enzymatisch spaltbare Linker für Festphasensynthesen
JP2000281539A (ja) * 1999-01-29 2000-10-10 Seiwa Kasei:Kk 化粧品基材
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
WO2003042387A1 (fr) * 2001-11-13 2003-05-22 Keio University Nouvelles proteines associees a la keratine des poils
US20040253606A1 (en) * 2002-11-26 2004-12-16 Protein Design Labs, Inc. Methods of detecting soft tissue sarcoma, compositions and methods of screening for soft tissue sarcoma modulators

Also Published As

Publication number Publication date
EP1763334A2 (de) 2007-03-21
RU2006145670A (ru) 2008-06-27
ES2317237T3 (es) 2009-04-16
ATE417595T1 (de) 2009-01-15
RU2411029C9 (ru) 2011-10-20
MXPA06013458A (es) 2007-03-01
NZ551366A (en) 2009-01-31
US20080075684A1 (en) 2008-03-27
DE502005006284D1 (de) 2009-01-29
JP2008500301A (ja) 2008-01-10
AU2005247092B2 (en) 2010-01-07
CA2563999A1 (en) 2005-12-08
AU2005247092A1 (en) 2005-12-08
WO2005115306A2 (de) 2005-12-08
WO2005115306A3 (de) 2006-03-16
EP1763334B1 (de) 2008-12-17
RU2411029C2 (ru) 2011-10-20

Similar Documents

Publication Publication Date Title
BRPI0511421A (pt) composições cosmética e farmacêutica para tratar materiais contendo queratina, uso de composições cosméticas, molécula efetora que liga queratina, uso da mesma, e, processo
ES2557402T3 (es) Fragmentos peptídicos para inducir la síntesis de proteínas de la matriz extracelular
Dekan et al. Total synthesis of human hepcidin through regioselective disulfide‐bond formation by using the safety‐catch cysteine protecting group 4, 4′‐dimethylsulfinylbenzhydryl
BRPI0409924A (pt) ácidos amino carboxìlicos substituìdos
BRPI0413728A (pt) muteìnas de lipocalina da lágrima
BRPI0411172A (pt) peptìdeo, dìmero de peptìdeo, seu uso e composição farmacêutica
CY1110973T1 (el) Βελτιωμενα διμερη sgp130fc
EA200800368A1 (ru) Гликозилированный il-7, получение и применение
NO20092774L (no) HLA-A*1101-begrenset WT1-peptid og farmasoytisk preparat som omfatter dette
BRPI0510428A (pt) composições tópicas de metadona e processos para utilização das mesmas
Gibson et al. Design of peptidyl compounds that affect β-amyloid aggregation: importance of surface tension and context
BR9910573A (pt) Compostos antipicornavirais, preparação e uso dos mesmos
Sivanesam et al. Peptide Inhibitors of the amyloidogenesis of IAPP: verification of the hairpin‐binding geometry hypothesis
KR102077983B1 (ko) 피부 주름 개선 및 미백용 조성물
ATE506957T1 (de) Prophylaktisches/therapeutisches mittel für neurodegenerative erkrankungen
Thomas et al. Proline editing: a divergent strategy for the synthesis of conformationally diverse peptides
Lengyel et al. Introduction of cyclically constrained γ-residues stabilizes an α-peptide hairpin in aqueous solution
BR122018077204B8 (pt) peptídeos da proteína humana de estresse térmico, composição farmacêutica, e, uso do peptídeo e da composição farmacêutica
DE69900756T2 (de) Verwendung von hmg proteinen zur herstellung von arzneimitteln mit zytotoxischer wirkung
KR102093093B1 (ko) 피부 노화 개선용 조성물
WO2006097432A3 (de) Keratin-biktdende desmoplakinpolypeptidsequenzen
EA201100459A1 (ru) Композиции, включающие интерлейкин-1 и пептиды
BRPI0415781A (pt) método para o tratamento de diabetes em um paciente e kit farmacêutico
WO2006075253A3 (en) Peptides for desensitizing subjects allergic to dog hair and dander and compositions containing said peptides.
Kim et al. Purification and characterization of antimicrobial peptides from the skin secretion of Rana dybowskii

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DA 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2204 DE 02/04/2013.